The Managed Care Pre-Launch Compass examines access, utilization management, and reimbursement issues to provide a 360° view on category dynamics and trends that will impact market entry.
The report is compiled from across the ZHI portfolio of proprietary, syndicated sources and reflects the most up-to-date managed care trends for a designated therapeutic class – accounting for anticipated new entrants and generic/biosimilar shifts.
Obtain a comprehensive 360° analysis of the access environment to enable launch coverage success including payer management, prescriber implications, and competitive messaging
Use the most actionable data to help key internal stakeholders, such as Brand, Payer Marketing, Analytics, Contracting, and Senior Leadership navigate the ever evolving access marketplace
Compare current payer landscape for similar products to understand the dynamics that matter most
Understand how future payer trends impact decision-making and drug launch planning
Identify how new drugs or generics will affect the current market
Understand current and future utilization management hurdles and opportunities, by category
Benchmark existing brand strategies against anticipated drug launch strategy
An essential pre-launch planning tool, the Pre-Launch Compass (PLC) identifies key opportunities and challenges, and provides actionable insights to help all stakeholders navigate the evolving access landscape.